Aptevo Therapeutics Inc logo

Aptevo Therapeutics Inc

NAS:APVO (USA)  
$ 0.44 -0.0309 (-6.56%) 10:08 PM EST
At Loss
P/B:
0.05
Enterprise V:
$ -1.65M
Volume:
11.19M
Avg Vol (2M):
8.59M
Trade In:
Volume:
11.19M
At Loss
Avg Vol (2M):
8.59M

Business Description

Description
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Financials (Next Earnings Date:2024-08-09 Est.)

APVO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APVO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aptevo Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -99.411
Beta 1.34
Volatility % 93.61
14-Day RSI 46.18
14-Day ATR ($) 0.090636
20-Day SMA ($) 0.391762
12-1 Month Momentum % -98.54
52-Week Range ($) 0.2848 - 50.16
Shares Outstanding (Mil) 7.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aptevo Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Aptevo Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aptevo Therapeutics Inc Frequently Asked Questions

What is Aptevo Therapeutics Inc(APVO)'s stock price today?
The current price of APVO is $0.44. The 52 week high of APVO is $50.16 and 52 week low is $0.28.
When is next earnings date of Aptevo Therapeutics Inc(APVO)?
The next earnings date of Aptevo Therapeutics Inc(APVO) is 2024-08-09 Est..
Does Aptevo Therapeutics Inc(APVO) pay dividends? If so, how much?
Aptevo Therapeutics Inc(APVO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1